Published in Cell Immunol on June 01, 1989
Neurovascular damage in experimental allergic encephalomyelitis: a target for pharmacological control. Mediators Inflamm (1997) 0.79
Experimental allergic encephalomyelitis and autoimmune disease. Adv Immunol (1966) 3.74
Spontaneous in vitro reduction of nitroblue tetrazolium by neutrophils of adult patients with bacterial infection. N Engl J Med (1971) 2.16
Vancomycin-streptomycin synergism in enterococcal endocarditis. JAMA (1973) 1.99
Counterimmunoelectrophoresis for rapid diagnosis of meningitis due to Diplococcus pneumoniae. J Infect Dis (1973) 1.86
Sequence-specific DNA binding by Ku autoantigen and its effects on transcription. Nature (1996) 1.75
Appendages of Clostridium bifermentans spores. J Bacteriol (1967) 1.67
Mucocutaneous candidiasis, anergy and a plasma inhibitor of cellular immunity: reversal after amphotericin B therapy. Clin Exp Immunol (1971) 1.66
Experimental allergic encephalomyelitis: role of fibrin deposition in immunopathogenesis of inflammation in rats. Fed Proc (1976) 1.62
i-Phone applications for the modern day otolaryngologist. Clin Otolaryngol (2010) 1.53
Localization of C-reactive protein in inflammatory lesions of experimental allergic encephalomyelitis. Clin Exp Immunol (1981) 1.48
Further electron microscope characterization of spore appendages of Clostridium bifermentans. J Bacteriol (1968) 1.39
Crystalline inclusions of Clostridium cochlearium. J Bacteriol (1968) 1.37
Geographic structure of mitochondrial and nuclear gene polymorphisms in Australian green turtle populations and male-biased gene flow. Genetics (1997) 1.27
In vitro demonstration of cellular sensitivity in allergic encephalomyelitis. J Exp Med (1965) 1.22
Current perspectives of neuroimmunologic disease: multiple sclerosis and experimental allergic encephalomyelitis (1,2). Clin Immunol Rev (1983) 1.16
Evolution of the T-cell repertoire during the course of experimental immune-mediated demyelinating diseases. Immunol Rev (1995) 1.15
Rapid induction of experimental allergic thyroiditis in rats sensitized to thyroid-adjuvant and pertussis vaccine. J Immunol (1968) 1.14
Airborne measurements of ethene from industrial sources using laser photo-acoustic spectroscopy. Environ Sci Technol (2009) 1.11
Cyclophosphamide: effect on experimental allergic encephalomyelitis in Lewis rats. Science (1969) 1.08
Recruitment of octamer transcription factors to DNA by glucocorticoid receptor. Mol Cell Biol (1998) 1.06
Multiple sclerosis: an immunologic reassessment. J Chronic Dis (1973) 1.06
Induction of experimental allergic encephalomyelitis in Lewis rats. Int Arch Allergy Appl Immunol (1970) 1.03
Immune processes and infectious factors in central nervous system disease. Annu Rev Med (1969) 1.02
Intact B-cell activity is essential for complete expression of experimental allergic encephalomyelitis in Lewis rats. Cell Immunol (1982) 1.01
Spore fine structure in Clostridium cochlearium. J Bacteriol (1969) 0.98
N.B.T. tests in a patient on steroids. Lancet (1971) 0.98
Induction of experimental allergic encephalomyelitis in Lewis rats with purified synthetic peptides: delineation of antigenic determinants for encephalitogenicity, in vitro activation of cellular transfer, and proliferation of lymphocytes. Proc Natl Acad Sci U S A (1985) 0.96
Selective binding of steroid hormone receptors to octamer transcription factors determines transcriptional synergism at the mouse mammary tumor virus promoter. J Biol Chem (1999) 0.96
Adjuvants, cell-mediated immune responses and autoimmune disease. J Reticuloendothel Soc (1973) 0.94
Cyclophosphamide inhibition of experimental allergic encephalomyelitis and cellular transfer of the disease in Lewis rats. J Immunol (1969) 0.94
Sequence-specific binding of Ku autoantigen to single-stranded DNA. J Biol Chem (1998) 0.93
In vitro effects of phytohemagglutinin and brain antigen on cell transfer of experimental autoimmune encephalomyelitis in Lewis rats. J Immunol (1968) 0.93
Erythromycin-resistant pneumococcal osteomyelitis. Am J Med (1970) 0.93
The binding of Ku antigen to homeodomain proteins promotes their phosphorylation by DNA-dependent protein kinase. J Biol Chem (2001) 0.92
Role of the clotting system in the pathogenesis of neuroimmunologic disease. Fed Proc (1987) 0.90
A double-blind randomised clinical trial of the treatment of otitis externa using topical steroid alone versus topical steroid-antibiotic therapy. Eur Arch Otorhinolaryngol (2008) 0.90
Rheumatic carditis: in vitro responses of peripheral blood leukocytes to heart and streptococcal antigens. Arthritis Rheum (1973) 0.90
Complement-fixing antibrain antibodies and allergic encephalomyelitis. II. Further studies concerning their protective role. Ann N Y Acad Sci (1965) 0.90
Immunosuppression and the Guillain-Barré syndrome. Arch Neurol (1970) 0.90
Chemical cross linking subtraction (CCLS): a new method for the generation of subtractive hybridisation probes. Nucleic Acids Res (1992) 0.88
Effect of indomethacin treatment upon actively-induced and transferred experimental allergic encephalomyelitis (EAE) in Lewis rats. Clin Exp Immunol (1982) 0.88
Antigen-specific tolerance as a therapy for experimental autoimmune encephalomyelitis. Int Rev Immunol (1992) 0.88
Neurovascular permeability and fibrin deposition in the central neuraxis of Lewis rats with cell-transferred experimental allergic encephalomyelitis in relationship to clinical and histopathological features of the disease. J Neuroimmunol (1993) 0.87
Cyclophosphamide treatment of experimental allergic encephalomyelitis in Lewis rats. J Immunol (1971) 0.87
Experimental allergic encephalomyelitis in suckling Lewis rats: comparison with the disease in adult animals. Lab Invest (1977) 0.87
Cellular transfer of experimental allergic encephalomyelitis employing suckling and adult Lewis rats. J Clin Lab Immunol (1981) 0.87
Cellular transfer of experimental allergic encephalomyelitis: altered disease pattern in irradiated recipient lewis rats. Cell Immunol (1975) 0.87
Induction of experimental allergic encephalomyelitis in suckling Lewis rats: role of age and type of sensitizing neuroantigen. J Immunol (1977) 0.86
Autoimmune diseases of myelin. Prog Clin Biol Res (1980) 0.85
Formation of protoplasts in Azotobacter vinelandii. Arch Microbiol (1974) 0.84
Cerebrospinal fluid and serum oligoclonal IgG bands in rabbits with experiment allergic encephalomyelitis. Neurochem Res (1981) 0.84
Cellular transfer of experimental allergic encephalomyelitis in Lewis rats: effects of different sensitization regimens on in vitro reactivity of donor spleen cells to concanavalin A. Cell Immunol (1981) 0.83
Endogenous myelin basic protein-serum factors (MBP-SFs) and anti-MBP antibodies in humans. Occurrence in sera of clinically well subjects and patients with multiple sclerosis. J Neurol Sci (1981) 0.83
Cyclophosphamide in exacerbations of multiple sclerosis. Therapeutic trial and a strategy for pilot drug studies. J Neurol Neurosurg Psychiatry (1975) 0.83
Adjuvanticity of mycobacterial RNA and poly A:U for induction of experimental allergic encephalomyelitis in guinea pigs. J Immunol (1973) 0.83
Cyclosphosphamide inhibition of experimental allergic thyroiditis and thyroid antibody production in rats. J Immunol (1971) 0.83
Interleukin 1 and myelin basic protein synergistically augment adoptive transfer activity of lymphocytes mediating experimental autoimmune encephalomyelitis in Lewis rats. J Immunol (1987) 0.83
Studies of cyclophosphamide suppression of experimental allergic encephalomyelitis in Wistar rats. J Immunol (1969) 0.83
Molecular and cellular determinants of neuroimmunologic inflammatory disease. Fed Proc (1982) 0.83
Myelin basic protein serum factor (MBP-SF) in adult Lewis rats: a method for detection and evidence that MBP-SF influences the appearance of antibody to MBP in animals developing experimental allergic encephalomyelitis. Immunochemistry (1978) 0.83
Occurrence and erythromycin susceptibility of penicillin-resistant Viridans streptococci in rheumatic fever patients on oral penicillin prophylaxis. Antimicrob Agents Chemother (Bethesda) (1968) 0.82
Role of macrophage-myelin basic protein interaction in the induction of experimental allergic encephalomyelitis in Lewis rats. J Immunol (1983) 0.82
Myelin basic protein serum factor. An endogenous neuroantigen influencing development of experimental allergic encephalomyelitis in Lewis rats. J Exp Med (1978) 0.82
Potentiation of experimental allergic encephalomyelitis in hamsters with persistent encephalitis due to measles virus. J Infect Dis (1979) 0.82
Epitope and functional specificity of peripheral tolerance induction in experimental autoimmune encephalomyelitis in adult Lewis rats. J Immunol (1994) 0.82
Thyroid hormone and androgen regulation of nerve growth factor gene expression in the mouse submandibular gland. Mol Cell Endocrinol (1992) 0.82
Cerebrospinal fluid beta-glucuronidase activity in rabbits with experimental allergic encephalomyelitis. Clin Exp Immunol (1970) 0.82
Methicillin resistant Staphylococcus aureus: is it a problem for nasal surgery? J Laryngol Otol (2006) 0.81
Microbial parasitism cross-reactive with host antigen: implications concerning loss of "self" tolerance and development of autoimmune disease. Recomb DNA Tech Bull (1981) 0.81
Antigen-specific inhibition of the adoptive transfer of experimental autoimmune encephalomyelitis in Lewis rats. J Neuroimmunol (1992) 0.81
A tiered risk-based approach for predicting diffuse and point source phosphorus losses in agricultural areas. Sci Total Environ (2005) 0.81
Endogenous myelin basic protein-serum factors (MBP-SFs) in Lewis rats. Evidence for their heterogeneity and reactivity with anti-MBP antibodies of different affinities. J Neurol Sci (1981) 0.81
Experimental allergic encephalomyelitis (EAE) in mice selectively bred to produce high affinity (HA) or low affinity (LA) antibody responses. Immunology (1990) 0.80
Developmental effects of ectopic expression of the glucocorticoid receptor DNA binding domain are alleviated by an amino acid substitution that interferes with homeodomain binding. Mol Cell Biol (1999) 0.80
The effect of antisera against rat immunoglobulins on cellular transfer of experimental allergic encephalomyelitiin Lewis rats. Clin Exp Immunol (1970) 0.80
Specific cell binding using staphylococcal protein A magnetic microspheres. J Pharm Sci (1981) 0.80
MBP-SF, a prominent serum factor in suckling Lewis rats that additively inhibits the primary binding of myelin basic protein (MBP) to syngeneic anti-MBP antibodies. Immunochemistry (1978) 0.80
Urine beta-glucuronidase in renal injury. I. Enzyme assay conditions and response to mercuric chloride in rats. J Lab Clin Med (1969) 0.80
Suppression of clinical signs of cell-transferred experimental allergic encephalomyelitis and altered cerebrovascular permeability in Lewis rats treated with a plasminogen activator inhibitor. Cell Immunol (1987) 0.80
Reversal of experimental allergic thyroiditis in cyclophosphamide-treated rats. Clin Exp Immunol (1975) 0.80
Cyclophosphamide inhibition of experimental allergic encephalomyelitis in Wistar rats. Proc Soc Exp Biol Med (1967) 0.79
Neuroimmunologic disease: experimental and clinical aspects. Hosp Pract (1979) 0.79
Immunologic determinants of experimental neurologic autoimmune disease and approaches to the multiple sclerosis problem. Trans Am Clin Climatol Assoc (1978) 0.79
Urine beta-glucuronidase in renal injury. II. Excretion patterns in experimental staphylococcal pyelonephritis in rats. J Lab Clin Med (1969) 0.79
Joseph E. Smadel Memorial Lecture: neuroimmunologic diseases of animals and humans. Rev Infect Dis (1980) 0.79
Temporal dissociation of experimental allergic encephalomyelitis transfer activity and gamma globulin staining of lymphoid cells from sensitized Lewis rats. J Immunol (1970) 0.79
Irradiation potentiation of cellular transfer of EAE: time course and locus of effect in irradiated recipient Lewis rats. Cell Immunol (1978) 0.78
Spatiotemporal statistical modelling of long-term change in river nutrient concentrations in England & Wales. Sci Total Environ (2013) 0.78
Serum degradation of myelin basic protein with loss of encephalitogenic activity: evidence for an enzymatic process. Cell Immunol (1978) 0.78
LT/EAE and the MS quest. Going to the dogs and rats to study the patient. Cell Immunol (1983) 0.78
Encephalitogenic and proliferative responses of Lewis rat lymphocytes distinguished by position 75- and 80-substituted peptides of myelin basic protein. J Immunol (1989) 0.78
Platinum-folate compounds: synthesis, properties and biological activity. Adv Enzyme Regul (1987) 0.78
Immunosuppression and the Guillain-Barré syndrome. Neurology (1970) 0.78
Increased severity of experimental autoimmune encephalomyelitis in rats tolerized as adults but not neonatally to a protective TCR V beta 8 CDR2 idiotope. J Immunol (1995) 0.78
The N- and C-terminal boundaries of myelin basic protein determinants required for encephalitogenic and proliferative responses of Lewis rat T cells. J Neuroimmunol (1990) 0.78
Experimental allergic encephalomyelitis supernatant transfer activity (EAE-STA) in Lewis rats:immunobiologic and initial biochemical properties. J Immunol (1980) 0.77
Morphology and nucleic acid composition of the Azotobacter bacteriophages. J Virol (1972) 0.77
Concordance and localization of maximal vascular permeability change and fibrin deposition in the central neuraxis of Lewis rats with cell-transferred experimental allergic encephalomyelitis. J Neuroimmunol (1992) 0.77
Neurovascular fibrinolytic activity in normal Lewis rats and rats with cell-transferred experimental allergic encephalomyelitis. J Neuroimmunol (1990) 0.77
Spore appendages and taxonomy of Clostridium sordellii. J Bacteriol (1971) 0.76